Skip to main content
Caplight Logo









Canomiks

Canomiks

Private
Rochester, MinnesotaHealthcare & Life Scienceshttps://canomiks.com

Last Round

Grant

Jun 15, 2024

Est. Valuation

$333,000

Total Funding Raised

$1.55M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Canomiks is a life sciences company that offers a genomics and AI-based technology platform to test and validate the biological efficacy and safety of ingredients for the functional food, beverage, and dietary supplement industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Quality Management, Compliance & Risk, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

genomicsbioinformaticsingredient testingproduct certificationdietary supplement testingbiological validationfunctional food testingAI-powered genomicsregulatory compliancebiotech servicesin silico testingprecision nutritionCPG quality controldrug discoveryhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Canomiks Comparables

Compare Canomiks with similar companies based on industry and business-model similarity.

Canomiks comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PIPA LLC
82%
Radicle Science
78%
NemaLife
76%

Canomiks Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 15, 2024
GrantOct 25, 2022
GrantApr 1, 2022
GrantDec 14, 2021
GrantSep 20, 2021
Grant
Jan 11, 2021

Key People

Founding team and executive leadership

Leena Pradhan-Nabzdyk

CEO Co-Founder

Founding Team

Canomiks Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 47% MoM, reaching 2K.

  • Jun 19, 2025

    WhatToTrust platform launched for the dietary supplements market.

Canomiks Filings

Explore SEC and related filing metadata, where available.

Canomiks filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Canomiks's valuation, stock price, and market status.

Is Canomiks a public or private company?

Canomiks is a private company.

What is the current stock price of Canomiks?

Canomiks is a private company, so its shares have no public market price. Caplight tracks Canomiks's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Canomiks worth (valuation)?

Canomiks's valuation is estimated at $333.0K based on funding round data.

Can I buy Canomiks stock?

Canomiks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Canomiks's last funding round?

Canomiks's most recent funding round was Grant on June 15, 2024.

Who are the main investors in Canomiks?

Key investors in Canomiks include Techstars.

Will Canomiks IPO soon?

No public IPO plans have been announced for Canomiks.

How can I track Canomiks secondary market activity?

Caplight tracks bids, offers, and trades in Canomiks's shares on secondary markets.

Firmographic Details

HeadquartersRochester, Minnesota
Employee Range4
Year Founded2016
Last FundingJun 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?